A A+ A A A


CBmed projects aim to develop easily applicable, targeted, minimally invasive biomarkers for better diagnosis, better therapy monitoring and a more personalized treatment of patients. 


1.1 Clinical information systems for biobanks
1.2 Semantic data management
1.3 Knowledge discovery and advanced interactive data mining *)
1.4 Next generation sequencing-based biomarkers in molecular pathology
1.5 Metabolomics platform for biomarker research
1.6 Immunology platform for biomarker research
1.7 Health technology assessment
1.8 Digital pathology
1.9 Clinical MALDI application




2.2 Tracking the trace: Detection, selection and target evaluation of cellular and cell free cancer biomarkers
2.4 Minimal residual disease detection as a prognostic biomarker and therapeutic target in hematologic malignancies using monoclonal antibodies and development of therapeutic chimeric antibody receptor (CAR) T cells
2.5 Genomic, transcriptomic and proteomic evaluation of eukaryotic initiation factors (eIFs) in various tumour entities
2.7 ADX models for the evaluation of cancer treatments
2.8 Core lab for target identification and probe development




3.1 Biomarkers to address diabesity
3.2 Biomarkers in early detection and risk assessment of cardiovascular disease
3.3 Biosensors for short-living biomarkers
3.4 Biomarkers of bone metabolism and related organ systems
3.5 Biomarkers in the regulation of fertility
3.6 Minimally-invasive biomarkers for liver function
3.9 Biomarkers for probiotic effects on microbiome–gut–brain axis
3.10 Biomarkers for early sepsis detection
3.11 Molecular signatures as biomarkers of invasive fungal infections
3.12 Electrochemical biomarker detection in common metabolic disorders

  *) project already finished


Details will follow soon.



Find our partners here.